Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction

Lara S F Konijnenberg1, Peter Damman1, Dirk J Duncker2

  • 1Department of Cardiology, Radboud University Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands.

Cardiovascular Research
|November 12, 2019
PubMed

Insights

Primary percutaneous coronary intervention (PCI) restores epicardial artery blood flow in ST-elevation myocardial infarction (STEMI) but often fails to restore microvascular perfusion, leading to worse outcomes. This review explores coronary microvascular dysfunction (CMD) in STEMI.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomedical Engineering

Background:

  • Primary percutaneous coronary intervention (PCI) is the standard treatment for ST-elevation myocardial infarction (STEMI).
  • Despite successful epicardial artery reperfusion in >95% of STEMI cases, approximately half of patients develop coronary microvascular dysfunction (CMD).
  • Post-ischaemic CMD is linked to increased morbidity and mortality in STEMI patients.

Purpose of the Study:

  • To review diagnostic and quantification techniques for CMD in STEMI.
  • To explore the pathophysiology of CMD using in vitro and in vivo experimental models.
  • To discuss future therapeutic strategies for CMD in STEMI.

Main Methods:

  • Review of invasive and non-invasive diagnostic techniques for CMD.
  • Analysis of experimental data from in vitro and in vivo models of myocardial infarction.
  • Synthesis of current literature on CMD pathophysiology and treatment.

Main Results:

  • Angiographically complete epicardial reperfusion does not guarantee microvascular function restoration.
  • Ischaemia, reperfusion injury, and inflammation significantly impact coronary microvascular endothelial cells.
  • CMD diagnosis and quantification methods are crucial for risk stratification.

Conclusions:

  • Coronary microvascular dysfunction (CMD) remains a significant challenge post-ST-elevation myocardial infarction (STEMI) despite successful epicardial reperfusion.
  • Understanding the mechanisms of CMD is vital for developing targeted therapies.
  • Further research into preventing and treating CMD is essential for improving STEMI patient outcomes.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
176
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
318
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
665
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
322
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
216
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
311